Targeting maladaptive anger with brief therapist-supported internet-delivered emotion regulation treatments: A randomized controlled trial.


Journal

Journal of consulting and clinical psychology
ISSN: 1939-2117
Titre abrégé: J Consult Clin Psychol
Pays: United States
ID NLM: 0136553

Informations de publication

Date de publication:
May 2023
Historique:
medline: 22 5 2023
pubmed: 22 11 2022
entrez: 21 11 2022
Statut: ppublish

Résumé

To evaluate the relative impact of three brief therapist-supported internet-delivered emotion regulation treatments for maladaptive anger (mindful emotion awareness [MEA], cognitive reappraisal [CR], and mindful emotion awareness + cognitive reappraisal [MEA + CR]) and to test whether baseline levels of anger pathology moderate treatment outcome. Treatments were evaluated in a randomized controlled trial. In total, 234 participants (59% female; mean age = 41.1, SD = 11.6) with maladaptive anger were randomized to MEA (n = 78), CR (n = 77), or MEA + CR (n = 79). Self-reported primary and secondary outcomes were followed up at primary endpoint, 3 months after treatment termination (88% retention). Primary outcomes were also assessed weekly during a prolonged baseline phase (4 weeks) and an active treatment phase (4 weeks). At the primary endpoint, the MEA + CR was superior in terms of anger expression (d = 0.27 95% confidence interval, CI [0.03, 0.51]), aggression (d = 0.43 [0.18, 0.68]), and anger rumination (d = 0.41 [0.18, 0.63]). MEA + CR was particularly effective in reducing anger expression (d = 0.66 [0.21, 1.11]), aggression (d = 0.90 [0.42, 1.39]), and anger rumination (d = 0.80 [0.40, 1.20]) for individuals who reported high values (+1SD) of the outcomes at baseline. Brief therapist-supported internet-delivered MEA and CR treatments are effective interventions for maladaptive anger. Combining MEA and CR is especially effective in reducing anger expression and aggression, particularly, in individuals who report higher levels of initial anger pathology. The present study highlights the importance of emotion regulation as an important treatment target for reducing maladaptive anger. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Identifiants

pubmed: 36409100
pii: 2023-20193-001
doi: 10.1037/ccp0000769
doi:

Banques de données

ClinicalTrials.gov
['NCT03858296']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-266

Subventions

Organisme : Knut and Alice Wallenberg Foundation

Auteurs

Johan Bjureberg (J)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet.

Olivia Ojala (O)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet.

Anton Berg (A)

Department of Behavioural Sciences and Learning, Linköping University.

Elin Edvardsson (E)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet.

Örn Kolbeinsson (Ö)

Department of Behavioural Sciences and Learning, Linköping University.

Olof Molander (O)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet.

Evelina Morin (E)

Department of Behavioural Sciences and Learning, Linköping University.

Line Nordgren (L)

Department of Behavioural Sciences and Learning, Linköping University.

Kristin Palme (K)

Department of Behavioural Sciences and Learning, Linköping University.

Josefin Särnholm (J)

Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet.

Leif Wedin (L)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet.

Christian Rück (C)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet.

James J Gross (JJ)

Department of Psychology, Stanford University.

Hugo Hesser (H)

Department of Behavioural Sciences and Learning, Linköping University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH